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C. caviae Chlamydophila caviae LGV Ivmphogranuloma venereum
C. muridarum Chlamydia muridarum MCP monocyte chemotactic protein
C. pneumoniae Chlamydophila pneum oniae MIP macrophage inflammatory
C. trachomatis Chlamydia trachomatis protein
C.ps ittad Chlamydophila psittaci MMP mátrix metál loproteinase
CSF colony stimulating factor MOI multiplicity of infection
EB elementary body MOMP major outer membráné protein
ECM extracellular mátrix VFKB nuclear factor - kappa béta
ET endothelin nMD normál ized médián density
FABP fatty acid binding protein nPCR nested PCR
FBS fetal bovine serum p.i post infection
FGF fíbroblast growth factor PBMC peripherial blood mononuclear
GAG glucoseaminogiycane cell
GPIC guinea pig inclusion PDGF platelet derived growth factor
conjunctivitis pm p polymorphic membráné
GRO growth related oncogene protein
HBEGF heparin binding epitheiial PPBP pro-platelet basic protein
growth factor RB reticulate body
hsp heat shock protein TEM transmission electron
IFU infectious unit microscopy
IKB inhibitor of nuclear factor - TNF tumor necrosis factor
kappa béta
Chlamydophila pneumoniae (C. pneumoniae) is an obligate intraceilular bacterium 
primarily associated with respiratory infections, including pneumonia and bronchitis. It is 
widely distributed in the population, and by age 20, ~50% of the population of the 
developed world is seropositive (Grayston 2000). Infection with the bacterium has been 
suggested to contribute to the initiation and/or progression of a variety of ehroníc 
inflammatory diseases, including multiple sclerosis (Yucesan and Sriram 2001), asthma 
(Esposito and Principi 2001) and atherosclerosis (Campbell, Kuo et al. 1998). 
Atherosclerotic míddle cerebral arteries are frequent sites of thrombosis, leading to stroke. 
However, the presence o f this pathogen in atherosclerotic middle cerebral arteries has nőt 
been documented. We analyzed atheromatous plaques from middle cerebral arteries fór the 
presence of C. pneumoniae. Atherosclerotic middle cerebral arteries from 15 cadavers who 
died of natural causes and corresponding nonatherosclerotic arteries from 4 otherwise 
healthy trauma victims were examined. Assavs fór C. pneumoniae DNA were carried out 
by nested polymerase chain reaction (nPCR) specific fór the C. pneumoniae ompA gene, 
The presence of the bacterium was assessed by transmission electron microscopy. Five of 
the 15 atherosclerotic artéria! samples and nőne of the control tissues were positive fór C  
pneumoniae by nPCR. Particles similar in morphology and size to C. pneumoniae 
elementarv bodies were detected by transmission electron microscopy in 4 of the 5 nPCR- 
positive atherosclerotic samples. The demonstration of C. pneumoniae in atherosclerotic 
middle cerebral arteries is consistent with the hvpothesis that this bacterium is involved in 
acute and chronic cerebrovascular diseases.
Humán moncvtes and monocyte derived macrophages are important cells fór both 
the spreading of C. pneumoniae, and the development of atherosclerosis. We studied the 
effect of infection with C. pneumoniae on hőst messenger RNA expression in humán 
monocytic cells with DNA microarravs. The data chronicle a Cascade of transcríptional 
events affecting 128 genes, many of which have nőt previously been reported to be affected 
by C. pneumoniae infection. Downregulated genes are primarily associated with RNA and 
DNA metabolism, chromosomal stability, and cell-cycle reguládon. Upregulated mRNAs 
include those fór a variety o f genes with important proíntlammatory functions such as
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monocyte chemotactic protein-1 (MCP-1), MCP-2, macrophage inflammatory protein- 
lalpha (M lP-la), MIP-t(3, M1P2-P, interleukin-lbeta (IL-1P) and mátrix
metalloproteinase-3 (MMP-3), MMP-10, MMP-12. We showed növel C. pneumoniae 
indueed hőst cell genes —including the hvaluron receptor CD-44, vasoconstrictor 
endothelin-1, the smooth muscle growth factor heparin-binding EGF-like growth factor, 
pro-platelet binding protein and fatty acid binding protein-4, coagulation factor-V—that 
had nőt been connected to C. pneumoniae monocyte infection before, bút had been 
previously described as characteristics fór the development of atherosclerosis and other 
chronic inflammatory diseases. We concluded that C. pneumoniae-infected monocytes can 
contribute to the development and progression of diseases fór which acute or chronic 
inflammation has been shown to be important, such as atherosclerosis.
Members of the genus Chlamydia exhibit marked differences ín hőst rangé and 
tissue tropism despite sharing a remarkable level of genomic synteny. These pathobiotype 
differences among chlamydiae are alsó mirrored in their early interactions with cultured 
mammalian hőst cells. Chlamydial attachment and entry is known to trigger protein 
tvrosine phosphorylation. We examined the kinetics and pattem of protein tyrosine 
phosphorylation indueed by infection with a comprehensive collection of chlamydial 
strains exhibiting diversity in hőst, tissue. and disease tropisms. We reported new findings 
showing that protein tyrosine phosphorylation pattems indueed by infection directly 
correlated with the pathobiotype of the infecting organism. Pattems of protein tyrosine 
phosphorylation were indueed following early infection that unambiguously categorized 
chlamydial pathobiotypes intő four distinct groups: (i) C. trachomatis trachoma biovars 
(serovars A to H), (ii) C. trachomatis lymphogranuioma venereum biovars (serovars Lt to 
Lj), (iii) C. muridarum, and (iv) C. pneumoniae and C. caviae, Notably, chlamydia infected 
murine and humán epithelial cells exhibited the same protein tyrosine phosphorylation 
pattems; this is indirect evidence suggesting that the phosphorylated protein(s) is of 
chlamydial origin. If our hypothesis is correct, these heretofore-uncharacterized proteins 
may represent a növel eláss of bacterial molecules that influence pathogen-host rangé or 
tissue tropism.
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Chlamydia genus contains obligate intracellular bacteria that are characterized bv a 
unique biphasic life cycle. Infection starts with the attachment of the infectious, 
metabolically non-active form of the bacterium. the elementary bodv (EB) to the hőst cell 
cytoplasm. The EB induces a hőst cytoskeletal rearrangement and phagocytosed or 
endocvtosed intő the hőst cytoplasm. The bacterium evades the fusion of the lysosomes bv 
an unknown mechanism, and relocates to the perinuclear space using the hőst microtubular 
network. The EB rapidly differentiates intő the metabolically active form of the bacterium, 
the reticulate body (RB). The RB undergoes multiple rounds of binary fission, in a 
protected niche called inclusion. The RB then transforms to EB and the infectious EBs are 
released from the hőst cell.
The main commonly studied strains of chlamydia are C. trachomatis, C. 
muridariim. C. pneumoniae and C.caviae. C. trachomatis multiplicates in the epithelial 
cells of the oculo-urogenital system and consist o f 15 major serovariants grouped intő two 
biovars the trachoma biovar (serovars A-K) and LGV biovar (serovars L1-L2-L3). Serovars 
A. B, Ba and C cause trachoma, an inflammation of the keratoconjunctiva that can lead to 
extensive scarring and eventually blindness. Serovars D-K cause local inflamation o f the 
urogenital system such as urethritis, cervicitis, endometritis, salpingitis. These pelvic 
inflammations alsó can lead to scarring, resulting tubái occlusion and ectopic pregnancy or 
infertility. Serovars L1-L2-L3 cause lymphogranuloma venereum. a disseminated infection 
of the urogenital system and the surrounding lymph nodes. C. trachomatis infection has 
great medical importance, this is the most common sexually transmited disease in the 
world. and the leading cause of preventable blindness (Thvlefors 1995; WHO 1996). The 
mouse strain of C. trachomatis is now called C. muridarum. This bacterium causes 
inflammation of the keratoconjunctiva, the urogenital system and the lung in mice. This 
strain is important, because the murine model is the most widely used animal model to 
mimic humán infection and fór vaccine development. The other medically important 
humán pathogen strain is the C. pneumoniae, that causes inflammation of the respiratory 
tract, and is suspected to be involved in a variety of chronic diseases, including multiple 
sclerosis (Yucesan and Sriram 2001), asthma (Esposito and Principi 2001), Sezary 
syndrome (Abrams, Balin et al. 2001), and atherosclerosis (Campbell, Kuo et al. 1998).
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C. caviae includes strains formerly belonging to C.psittaci guinea-pig inclusion 
conjunctivitis (GPIC) - a genetically close relatíve of C. pneumoniae. The primarv target 
tissue of the bacterium is the mucosal epithelium of guinea pigs resulting conjunctivitis and 
genital tract infections.
Despite the fact that the genome, the morphology, the unique biphasic 
developmental cycle are similar between the chlamydia strains, there are alsó signifícant 
differences in the dynamics of chlamydia infections nőt just in vivő bút in vitro. The C. 
trachomatis trachoma biovars and C. pneumoniae require centrifugádon fór efficient 
infection, and the trachoma biovars alsó requires DEAE-dextrane. There are additional 
differences: inhibition of the hőst cell's protein synthesis bv cycloheximide increases the 
growth of C. trachomatis trachoma biovars and C. pneumoniae, while others dön t require 
this treatment. The growth rate alsó varies between the strains: the C. trachomatis LGV 
biovars. C. muridarum and C.psittaci strains have short developmental cycle (24-36h), 
while C. trachomatis trachoma biovars and C. pneumoniae develop slowly in the hőst cells 
(~48h).
What is the source of these in vivő and in vitro differences between strains related 
to the same Chlamydia genus? The whole genome sequences of at least five chlamydial 
strains are available now (http://cmr.tigr.org/tigr-scripts/CMR/CmrHomePage.cgi). The 
differences at the genome level may help to explain the in vivő and in vitro phenotypic 
differences. One of the milestone papers in this fíeld is the C. pneumoniae and C. 
trachomatis comparative genomics paper (Kálmán. Mitchell et al. 1999). Analysis of the 
1,042,519 nucleotide length C. trachomatis genome and the 1,230,230 nucleotide length C. 
pneumoniae genome revealed that there were 894 and 1073 likely protein coding genes in 
the two genomes respectively. The fact that the two genus has a similar developmental 
cycle in the hőst cell, suggests that there is a high level of functional conservation between 
the two genomes. There are 859 protein coding genes in the C. pneumoniae genome that 
has orthologues to C. trachomatis genes. In addition to these core genes, there are 70 
unique C. trachomatis genes and 214 genes unique to C. pneumoniae likely responsible fór 
the differences in the in vivő virulence and in vitro growth. The detailed analysis of these 
genome differences is beyond the scope of this thesis, bút it is noteworthy that the major 
part of the increased genome size of C. pneumoniae is due to the expansion of the
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chlamydial polymorphic membráné protein family (pmp). Many of these genes were found 
to be on the chlamydial surface, and probably they are involved in ihe species-specifíc 
attachment and/ or entry (Christiansen, Pedersen et al. 2000).
During the entry, the EB binds to heparin or heparane suiphate glucosaminoglvcane 
attached hőst cell receptor, probably via its abundant ceJl surface molecule, the major outer 
membráné protein (MOMP) (Su, Raymond et al. 1996) and/or the heparin and heparane- 
sulphate molecules that alsó can be found on the surface of the EBs and hőst cells (Zhang 
and Stephens 1992). The attachment is followed by an actin-cytoskeleton reorganization, 
and entry intő the target cells (Carabeo, Grieshaber et al. 2002). The differences in 
attachment and the subsequent entry and entry-mediated signal-transduction can contribute 
to the observed in vivő hőst and tissue tropism. Indeed, C. pneumoniae uses the mannose 6- 
phosphate/ insulin-like growth factor receptor fór infection of humán endotelial cells, while 
the C. trachomatis E and L2 probably uses another hőst cell receptor fór attachment and 
entry (Puolakkainen. Kuo et al. 2005). There are differences in the subsequent chlamydia 
mediated hőst signal-transduction as well. C. trachomatis did nőt require the small Rho- 
GTPase cdc42 fór actin polvmerization during entry, while the entry of C. caviae GPIC 
needs cdc42 (Subtil, Wyplosz et al. 2004).
The receptor tyrosine kinase and other tyrosine kinase mediated tyrosine 
phosphorylation is an important part of the signal transduction cascade. There are several 
examples in other bacterial systems. that the bacterial attachment/entry processes is 
accompanied by the tyrosine phosphorylation of different groups of bacterial and hőst 
proteins. Enteropathogenic Escherichia coli (EPEC) bacterium uses a type III. secretion 
system to deliver its effector protein Tir intő the hőst epithelial cell, where the translocated 
protein becomes tyrosine phosphorylated (TirPY) (Kenny, DeVinney et al. 1997). The 
translocated Tir serves as a receptor fór the bacterium’s own ligand, the intimin protein. 
Interesingly, the tyrosine phosphorylation is nőt a requirement fór the Tir-Intímin bindíng, 
however the subsequent hőst actin-polymerisation and pedestal formation is dependent on 
the phopsphorylated Tir (Hawrani, Dempsey et al. 2003), Virulent Helicohacter pylori 
strains carry a cag pathogenicitv island containing a type IV. secretion system. One of the 
secreted bacterial effector proteins, CagA becomes tyrosine phosphorylated in the target 
cell and induces a global actin-cytoskeleton reorganization with a cell elongation
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phenotvpe (Segal, Cha et al. 1999). The phosphorylation of the CagA Y972 is required fór 
the hőst cell elongation (Backert, Moese et al. 2001).
The avaiiability of anti-phosphotyrosine antibodies made it possible to study the 
global tvrosine phosphorylation in response to a bacterial infection (Rosenshine, 
Donnenberg et al. 1992; Pace, Hayman et al. 1993; Segal, Falkow et al. 1996). The 
complex tvrosine phosphorylation pattem induced by chlamydia infection was alsó studied 
previously using pan-phosphotyrosine antibody (Birkelund, Johnsen et al. 1994; Fawaz, 
van Ooij et al. 1997; Stephens, Fawaz et al. 2000; Clifton, Fields et al, 2004). Fór 
Chlamydia, Birkelund et al. (Birkelund, Johnsen et al. 1994) described First that the C. 
trachomatis serovar L2 is capable to induce the tyrosine-phosphorylation of at least three 
groups of proteins, a ~64, 66, 68 kD triple bánd, a 97 kD and a 140 kD bands in HeLa 
humán epitheliai cells. Fawaz et al. alsó infected HeLa cells with C. trachomatis serovar L2 
and observed a tyrosine-phosphorylation in the 75kD region and the lOOkD region 
reproducibly and several high moleeular weight bands occasionally. Chloramphenicol and 
rifampycin pretreatment of the hőst cell did nőt influence the C. trachomatis serovar L2 
induced tyrosine phosphorylation. The protein phosphorylation was independent from 
either the hőst or chlamvdial de novo protein synthesis (Fawaz. van Ooij et al. 1997). The 
induced tyrosine-phosphorylation was MOI dependent: it could nőt be observed when MOI 
of 16 or less was used. The above described 64, 66, 68 kD triple bánd appeared at MOI of 
32, and a 97 kD and a 140 kD phosphoprotein appeared when MOI of >100 was used. The 
tyrosine phosphorylation of the 68-, 66-, and 64-kD triple bands could be detected as early 
as 15 min after infection of HeLa cells with C. trachomatis serovar L2. The intensity of the 
triple bánd reached maximum at 2 to 4 h postinfection and remained detectable as laté as 
16 hours post infection (Birkelund, Johnsen et al. 1994). The same time-course of tyrosine 
phosphorylation was observed by others (Fawaz, van Ooij et al. 1997) (Clifton, Fields et al. 
2004).
The tyrosine phosphorylation was adjacent to the chlamydia EB as soon as 30 
second post infection (Clifton, Fields et al. 2004). The tyrosine phosphorylated protein was 
located at the periphery of the cells two hours post infection. Similar to the movement of 
the chlamvdial EB itself, the tyrosine phosphorylated protein was migrated towards the 
perinuclear region of the hőst cells at four hours post infection. Eighteen hours post
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infection, when the EBs transformed to RBs and localized to the perinuclear region, the 
tyrosine phosphorylated proteins were seen as aggregates at the same region. Double 
labeling experiments showed that the tvrosine phosphorylated circular structures were 
identical to the chlamydial inclusions (Birkelund, Johnsen et al. 1994). Fawaz et al. alsó 
observed similar pattern of tyrosine phosphorylation and chlamydia immunoreactivity 
(Fawaz, van Ooij et al. 1997).
The chlamydia induced specifíc tyrosine-phosphorylation pattern was alsó observed 
in different mouse cell types, such as the mouse fibroblast cell line L929. the mouse 
monocyte-macrophage cell line RAW and the mouse macrophage-like cell line J774.1 
leading to the conclusion that the tyrosine-phosphorylation was nőt hőst cell species and 
cell-type specifíc. It is interesting that the observed tyrosine-phosphorylation pattern in the 
case of C. trachomatis serovar L2 were similar to the one described previously (Birkelund. 
Johnsen et al. 1994), however there was a significant size difference in the ~70 kD region 
between C. trachomatis L2 (~75 kD) and C. muridarum induced tyrosine phosphorylation 
(~85 kD) (Fawaz, van Ooij et al. 1997). The fact, that these phenotypically distinct strains, 
the mouse mucosal strain C. muridarum and the humán, non-mucosal. disseminating strain 
C. trachomatis serovar L2 induced different tyrosine phosphorylation in the target cells, 
suggests that may be one of the distinguishing features between the biologically different 
bút genotipically sometimes remarkably similar chlamydial strains is the way of entry. and 
particularly the pattern of the induced tyrosine-phosphorylated proteins.
Amongst the chlamydial strains significant evidences have been accumulated 
between C. pneumoniae infection and systemic chronic inflammatory diseases, particularly 
atherosclerosis. One o f the most current theory o f atherosclerosis is the response to injurv 
model. This model includes an endothelial malfunction or activation as a first step of the 
process. There are multiple traditional risk factors that can activate the endothelial layer 
such as cigarette smoking, hyperlipidaemia, hyperglycaemia, turbulent blood flow, 
circulating immuné complexes. This activation leads to increased expression of certain 
receptors such as E-selectin, P-selectin, ICAM-1, VCAM-l on the surface o f the 
endothelial cells. The blood monocytes start to roll and adhere to the activated endothelial 
cell layer using their endothelial receptor ligands E-selectin ligand-1, P-selectin 
glycoprotein ligand-1 and P l- and p2-integrins. After the attachment to the endothelium.
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the blood monocvtes transmigrate to the subendothelial space following a local MCP-1 
(monocyte chemotactic protein-1) and LL-8 chemokine gradient and differentiate to 
macrophage bv the local monocyte colony stimulating factor (M-CSF) and granulocvte- 
monocyte colony stimulating factor (GM-CSF). The macrophages express scavenger 
receptors SRA and CD-36, and accumulate a large amount of lipids in their cytoplasm. 
These lipid-laden macrophages are characteristic features of the early atherosclerotic 
lesion. This early plaque could develop further to the so-called complicated plaque. This 
development is characterized by a dynamic balance of tissue development and destruction 
in the véssél wall. The local macrophages start to express different mátrix 
metalloproteinases destructing the surrounding extracellular mátrix, and endothelial basal 
membranes. This process leads to plaque rupture. and the development of surface or 
intramural thrombus. The aggregated thrombocytes secrete piatelet derived growth factor 
(PDGF), a potent mitogen of the local smooth muscle cells and fibroblasts and in 
accordance with other local mitogens such as basic and acidic fibroblast growth factor 
(FGF) enhance the proliferation of fibroblasts and smooth muscle cells and extracellular 
mátrix production. This tissue growth and thrombus formation together significantly 
decrease the diameter of the véssél wall leading to clinical signs suchs acute myocardial 
infarct or stroke (fór a review of atherosclerosis development see (Libby 2002)).
In addition to the traditional risk factors, the role of certain infections in the initial 
endothelial injury was proposed almost 120 years ago (Gilbert A). More than twenty 
different pathogens have been studied, bút the strongest link was found between C. 
pneumoniae infection and atherosclerosis. The fírst study that found an elevated anti- 
chlamydia titer in patients with coronary atherosclerosis compared to healthv Controls was 
published by Saikku et al. in 1988 (Saikku, Leinonen et al. 1988).
Aíter this groundbreaking study, many follow-up studies showed a significant 
correlation between C, pneumoniae infection and atherosclerosis (Grayston 2000), 
however in most of the cases seropositivity only moderately increased the risk of 
atherosclerosis. Combination of C. pneumoniae seropositivity with other markers of 
inflammation, such as increased level of CRP, or other risk factors, such as smoking, can 
increase the risk significantly. Burian et al. showed that if the atherosclerotic patient group 
was divided intő subgroups based on e.g. the anti-human hsp60 titer, than the chlamvdia
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and humán hspóO seropositivity together had increased the risk of atherosclerosis 82 fold 
(Burian. Kis et al. 2001). This important studv suggests that chlamvdia infection acts 
together with other traditional risk factors in the development of atherosclerosis.
lmmunohistochemistry, electron microscopy, in situ hvbridization. PC'R and RT- 
PCR (Grayston 2000) studies alsó showed the presence of the pathogen's DNA and/ or 
protein in atherosclerotic tissues of various parts of the vascular system bút nőt or rarely 
from normál vessels. It is interesting that while one of the major consequences of laté 
atherosclerosis is the stroke, the presence of C. pneumoniae in intracerebral arteries has nőt 
been well investigated. Case-control studies revealed that specific anti-C. pneumoniae 
antibody levels were significantly higher in patients with cerebrovascular disease than in 
control patients, (Wimmer, Sandmann-Strupp et al. 1996; Cook, Honevboume et al. 1998; 
Elkind, Lin et al. 2000) and a follow-up study indicated that high antibody titers to C. 
pneumoniae were associated with an increased risk of future stroke (Fagerberg, Gnarpe et 
al. 1999). Immunoreactivity to C. pneumoniae-specific antigén was demonstrated in a low 
percentage of anterior and posterior cerebral arteries bút nőt in middle cerebral arteries 
(Vink, Poppen et al. 2001). ín addition to seroepidemiologv and molecular epidemiology 
several animal model experiments and antibiotic trials, although nőt uniformly alsó showed 
a link-between C. pneumoniae infection and atherosclerosis (Moazed, Kuo et al. 1996; 
Moazed, Kuo et al. 1997) (Moazed. Campbell et al. 1999; Blessing, Lin et al. 2000; 
Campbell, Rosenfeld et al. 2000; Sander, Winbeck et al. 2002; Higgins 2003; Sander, 
Winbeck et al. 2004).
Despite the fact that C. pneumoniae has been detected at various sites of the 
vascular tree, the exact mechanism of the spreading from the site o f the primary infection, 
the lung epithelial layer to different tissues, e.g the véssél wall is nőt known. The current 
model proposes a C. pneumoniae transfer from the infected lung epithelial cells to the local 
alveolar macrophages, and these cells serve as a vector to disseminate in the body. In a 
mouse chlamydia model it was showed that i, 3 days affér intranasal infection C. 
pneumoniae was detected in alveolar macrophages by culture and PCR ii, the transfer of 
infected alveolar macrophages to healthy mice lead to a systemic spreading. The pathogen 
was detected in the lung, spleen and abdominal lymph nodes of the recipient animal 
(Moazed. Kuo et al. 1998). However C. pneumoniae is nőt just using the monocytes-
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rnacrophages as a vector, bút stimulate these cells, activate them to roll and adhere to íhe 
endothelial layer of the véssél wall, transmigrate to the subendothelial space and to initiate 
and/ or boost the local inflammation. C. pneumoniae infected fluorescently labeled mouse 
rnacrophages showed a 3-fold increase o f rolling and 2-fold adherence to the carotid 
arteries compared to noninfected rnacrophages. The endothelial receptor ligands VLA-4, 
LFA-1, Mac-1 are upregulated in the infected rnacrophages (May, Redecke et al. 2003), 
and alsó these cells secrete a variety of proinflammatory proteins such as MCP-1, IL-8, 
TNF-a (Kothe, Dalhoff et al. 2000), MMP-1, MMP-9 (Kim, Gaydos et al. 2005), tissue 
factor (Bea, Puolakkainen et al. 2003) that are important part of the atherosclerosis 
pathology. The development of atherosclerosis is a long-term process, and írom this 
viewpoint it is noteworthy that while C. pneumoniae is able to survive inside the 
monocytes and rnacrophages fór several days (Kául and Wenman 2001) i, rnacrophages can 
transmit locally the infection to more susceptible cell lines such as endothelial cells (Lin, 
Campbell et al. 2000) and therefore maintain viable locally fór a longer period of time ii, 
after the descruction of the bacterium, acellular components of the chlamydia alsó can 
enhance local inflammation. Acellular, non-LPS components of the chlamydial véssél wall 
were able to induce MCP-1, 1L-1 (3, 1L-6, IL-8, M lP -la  (macrophage inflammatory 
protein-la). TNF-a in PBMCs in a TLR-2 dependent manner (Netea, Selzman et al. 2000; 
Netea. Kullberg et al. 2002). Chlamydial outer membráné proteins omp2, and the major 
outer membráné protein (MOMP) and hsp-60 induced a 92 kDa gelatinase production in 
humán monocyte derived rnacrophages (Vehmaan-Kreula, Puolakkainen et al. 2001). 
Moreover chlamydial LPS can induce the uptake of cholesteryl-ester and foam-cell 
formádon in the murine macrophage cell line RAW 264.7 (Kalayoglu and Byme 1998).
It is alsó noteworthy that C. pneumoniae can interact with other potentially 
proatherosclerotic pathogens such as humán cytomegalovirus to costimulate monocytes. 
We showed that C.pneumoniae and humán cytomegalovirus coinfected humán monocytoid 
cells produced significantly more proatherosclerotic genes, such as pro platelet basic 
protein and fattv acid binding protein-4 mRNA, than the singly infected or noninfected 
control (Virok, Kis et al. 2006). The same phenomena could alsó be observed in vivő. The 
early atherosclerotic foci induced by murine cytomegalovirus infection were significantly
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exacerbated following a single inoculation with C. pneumoniae (Burian, Berencsi et al. 
2001).
I started my PhD. studies at 1997 to investigate the link between atherosclerosis 
and C. pneumoniae. C. pneumoniae was detected from various sites of the vascular system, 
bút the presence of C. pneumoniae ’s DNA in somé pathologically important regions, such 
as in middle cerebral arteries was nőt studied earlier, despite the fact that these arteries are 
frequent sites of thrombosis leading to síroké. Moreover, while monocytes are essential fór 
both the dissemination of C. pneumoniae in the body, and the pathogenesis of 
atherosclerosis there was no large-scale dataset available about the impact of C. 
pneumoniae on the gene expression of monocytes. Finally, I extended my work to study the 
chlamvdia induced early tyrosine-phosphorylation pattems that distinguish between the 
different chlamydial strains during the early interaction with the hőst cell, the attachment 
and entry processes.
2.2. Aims
The present study was designated to address the following aims:
Aim 1. To determine the presence of C. pneumoniae in atherosclerotic and normál humán 
middle cerebral arteries.
Aim 2. To obtain a detailed description of C. pneumoniae infection on the gene expression 
of humán monocytes using the high-throughput DNA-chip method.
Aim 3. To determine whether there are differences between the major chlamydial strains 
during the early interaction of the hőst cell. particularly comparing the chlamvdia-induced 
early tyrosine-phosphorylation cascade.
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3. Materials and Methods
3. /. Study popuiation fór the identification o f  C. pneumoniae in atherosclerotic middle 
cerebral arteries
Atherosclerotic samples of middle cerebral arteries were obtained írom 15 
consecutively autopsied subjects. Samples were collected within 24 hours altér death with 
the use of sterilé instruments. Half of each sample was frozen at -70°C tor nested PC’R 
(nPCR) analysis; the other half was fixed in 3% glutaraldehyde fór TEM and histology. Fór 
control tissues. samples of 4 nonatherosclerotic middle cerebral arteries were collected 
írom trauma victims who died (at ages 31 to 40) during the study period. Histological 
assessment of the véssél samples írom the 15 patients indicated moderate or severe 
atherosclerotic stenosis. The control samples írom the trauma victims were assessed as 
histologically normál. The study was approved by an institutional review committee.
3.2. DNA extraction. C. pneumoniae specific nested PCR and transmission electron
microscopy
DNA was extracted rom frozen samples with the High Pure PCR Template Preparation 
Kit (Boehringer-Roche) according to the manufacturer’s instructions. Samples írom cases 
or Controls were tested in a blinded fashion fór C. pneumoniae DNA with a GeneApm 2400 
PCR system (Perkin-Elmer) with the use o f nPCR primer pairs specific fór the C. 
pneumoniae ompA gene (Tong and Sillis 1993) resulting in a 206-bp nPCR fragment. The 
presence of intact DNA was tested fór each sample with the use of primers specific fór the 
humán B-actin gene. DNA extracted from the lysate of C. pneumoniae-mfected McCov 
cells (both from American Type Culture Collection) was used as a positive control. The 
negative control was sterilé distilled water subjected to the same extraction procedure as 
used fór the tissue samples. Fór every set of 5 tested samples, nPCR including the negative 
control template was carried out. Strict precautions were taken to avoid contamination 
during DNA extraction and the preparation of the reaction mixture. Problems and 
limitations o f PCR were considered as suggested (Fredricks and Relman 1999; Pfaller
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2001) . DNA samples amplified bv the C. pneumoniae primers were sequenced with the 
ABI Prism DNA Sequencing Ready Detection Kit (Perkin-Elmer). Fixed samples of the 5 
C. pneumoniae nPCR-positive arteries and alsó the 5 C. pneumoniae nPCR-negative 
samples were postfixed in OsC>4 and embedded in Epon. Thin sections stained with uranvl 
acetate and lead citrate were examined by TEM. McCoy cells infected with C. pneumoniae 
were treated similarly fór morphological comparison.
3.3 C. pneumoniae propagation and inoculum preparation fó r  U937 humán monocytic cell
line infection.
C. pneumoniae (AR-39 strain; obtained from ATCC) was propagated in McCoy cells 
(ATCC CRL-1696), in MÉM with Earlesalts supplemented with 10% heat-inactivated fetal 
bovine serum (FBS), 0.5% glucose, 2 mmol/L L-glutamine, lx nonessential amino acids 
(Sigma), 8 mmol/L FiEPES, 25 pg/mL gentamycin, and 1 pg/mL cycloheximide. Infected 
cells were harvested on day 3 or 4 and then disrupted by 2 cycles of freeze-thawing and 
ultrasonication. Cell debris was removedby centrifugádon at 300 g  fór 10 min, and bacteria 
were concentrated by centrifugádon at 30,000 g fór 30 min. Pellets were resuspended in 
PBS (pH 7.4), mixed with an equal volumeof sucrose-phosphate-glutamic acid buffer(0.22 
mol/L sucrose, 10 mmol/L NaHíPCL, 3.8 mmol/L KH2PO4, and 5 mmol/L glutamic acid 
[pH 7.4]), formed intő aliquots, and frozen at -80°C until use. The same stock was used fór 
all experiments. Fór mock infection, uninfected McCoy cells were processed as described 
above and stored at -80°C. C. pneumoniae túrádon was performed on McCoy cells by use of 
immunofluorescent staining. Monolayers were infected with serial dilutions of concentrated 
bacteria, incubated tor 48 h, fixed with methanol/acetone (1 : 1), and stained with mouse 
anti-C. pneumoniae MOMP monoclonal antibody (Dako). Fluorescein isothiocyanate 
(FITC)-labeled anti-mouse IgG (goat F fab ^  anti-mouse IgG; Sigma) was used as a 
secondary antibody. After counting chlamydial inclusions under a fluorescent microscope, 
titers were expressed as inclusion-forming units per milliliter.
3.4 U937 humán monocytic cell line culture and infection
U937 cells were grown in 75-cm2 culture flasks in RPMI 1640 médium containing 10% 
heat-inactivated FBS and 50 pg/mL gentamycin at 37°C in 5% CO2. Before infection, the
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cells were transferred to 24-well plates at a density of 1 x I06 cells/well in RPMI 1640 
médium containing 10% heat-inactivated FBS, 0.5% glucose, and 10 mmol/L HEPES. 
U937 cells were infected with mycoplasma-free C. pneumoniae strain AR-39 stock at a 
multiplicity of 4 IFU/cell. Control cells were treated with the same volume of mock stock. 
Both were centrifuged at 600 g  fór 45 min at 30°C, during which time infection took piacé 
(Kuo and Grayston 1990). The plates were incubated at 37°C and 5% CCT, and infected and 
mock-infected cells were collected fór RNA extraction at 0, 2, 6, 10, 24, and 48 h afíer the 
centrifugádon. Note that the zero time point is taken immediately after the 45-min 
centrifugation o f the bacteria. during which time infection occurs. Cells were washed twice 
with 37°C médium used fór infection bet'ore extracting the RNA. Three indepenaent 
experiments monitored by cDNA arrays were performed. Two additional experiments with 
the same conditions were performed. to compare the C. pneumoniae MOMP and GroEL 
mRNA levels in hőst cells infected with live and heat-inactivated (at 60°C fór 40 min) C. 
pneumoniae.
3.5 Immunofluorescence and light microscopy o f  the infected U937 cells
Infected (MOl 4 IFU/cell) and mock-infected U937 cells were harvested 0, 2. 6. 10, 
24, and 48 h after infection, and cytospin preparations were made. Cells were fixed with 
ice-cold acetone and stained with monoclonal mouse anti-C. pneumoniae MOMP antibodv 
(Dako). This was followed by an FITC-conjugated anti-mouse secondary antibody (goat 
Ffab^]: anti-mouse IgG: Sigma). Stained cells were visualized with a confocal laser 
scanning microscope (model SP II; Leica).
3.6 Humán cDNA array production.
Escherichia coli isolates containing plasmids with a cloned insert specific fór a 
particular humán gene were obtained írom Research Genetics. Inserts were PCR amplified 
with the universal primersM13 JQ forward (5'-GTTTTCCCAGTCACGACGTTG-3’) and 
M13 JQ reverse (5’-TGAGCGGATAACAATTTCACACAG-3!) and were spotted onto a 
nylon filter by use of the GMS 417 arrayer (Affymetrix). Each array (HA03) contained 
2032 individual humán genes.
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3.7 U937 RNA amplification, hybridization, and scanning.
The RNA amplification procedure described elsewhere (Van Gelder, von Zastrow et al. 
1990) was followed, with slight modiíications. Details of the protocol can be found at 
http://showelab.wistar.upenn.edu. Labeled targets were prepared írom 0.6 pg of amplified 
RNA (aRNA) with Superscript II reverse transcriptase (Invitrogen), according to the 
manufacturer's directions, in the presence of 100 p.Ci of [o- PJ dCTP (Amersham- 
Pharmacia Biotech), 1 mmol/L dATP. 1 mmol/L dTTP, 1 mmol/L dGTP, 1 pg of oligo-dT 
(Promega Biosciences), and 1.5 pL of 10x random decamer (Ambion) primers. Labeled 
cDNA probes were hybridized to individual nylon arrays at 42°C fór 18 h. Arrays were 
washed twice in 2X standard saline citrate (SSC)/1% SDS solution fór 20 min at 50°C and 
were washed once in 0.5* SSC/1% SDS and 0. lx SSC/0.5% SDS fór 20 min at 55°C. 
Arrays were exposed to phosphor screens (Packard Instruments) fór 3-5 davs and were 
scanned in a Storm 820 Phosphorlmager (Molecular Dynamics). Quantitation of each spot 
was assessed by ArrayVision image anaiysis software (Image Research) and was exported 
to a Microsoft Excel fiié.
3.8 Data anaiysis ofgene expression.
Normalized signal intensities (nMDs) of individual spots were calculated by subtraction 
of local background intensity, followed by global normalization and division by the médián 
intensity of all the spots on the array. Statisticallv significant genes were selected írom a 
data set of 2032 genes, as described below. Infected versus mock-infected gene expression 
cutoffs. A paired t test between C. pneumoniae - and mock-infected cells was computed fór 
the expression of each gene over all time points fór the 3 replicates. In addition. a separate t 
test compared the values at each experimental time point in C. /wewmowae-infected cells to 
the values over all the time points fór the mock-infected Controls. This comparison allowed 
detection of transient expression changes in the experimental samples, which were masked 
by variability in the control experiments. To estimate the number of faise-positive findings 
at a time point, we took the 0-h values to be false positive and estimated the number o f true 
positives detected at 6 h and the later time points by subtracting the 0-h value at P < .05. 
Genes with P < .05 in any o f the 7 t tests described above were considered tor further 
anaiysis. This gene set was then further reduced by the procedures described below.
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Variance cutoff. The variance in the averages over replicates fór all time points in infected 
cells was compared with the analogous variance in mock-infected cells. Only genes with the 
ratio of variance (average [nMD(iní)])/variance average [nMD(mock)]) >3 passed this filter, 
which applied to the set of genes that passed the t tests above, selected genes with large 
changes in the infected cells, compared with mock-infected cells. Correlation cutoff. In 
addition, correlation was obtained between the time course of average gene expression in C. 
pneumoniae-'mfected cells and the time course in the mock-infected cells. Genes with 
correlations >0.9 were discarded. This filter eliminated genes that undergo the same 
changes in both infected and mock-infected cells. Time course cutoff. The genes, which 
passed the three filters described above, were subjected to an additional t test comparing the 
expression values in the C. pneumoniae-infected cells only. Depending on the gene 
expression profile, a / test was performed either between the lowest and highest point in the 
profile or between the continuous set of lowest values and the continuous set of highest 
values. Genes with P < .05 fór either of the t tests described above passed this filter. This 
filter selected genes that either increased or decreased significantly from their initial 
expression value. Data interpretation.The significant genes fulfilling all the criteria 
mentioned above were clustered by using either /F-means or hierarchical clustering (Eisen, 
Spellman et al. 1998) analysis based on the c-scores of nMDs from mock-infected and/or C. 
pneumoniae-infected cells ateach time point, by J-Express software.
3.9 Validation o f  cDNA array results by real-time PCR..
Either 0.6 pg of aRNA or 1 pg of totál RNA from C. pneumoniae-infected. heat- 
inactivated C. pneumoniae-infected, mock-infected, and untreated U937 cells harvested at 
10, 24, or 48 h after infection were reverse transcribed under the same conditions as in the 
labeling process. Primer design was based on the determined DNA sequence fór the clone 
spotted on the array by Light Cycler Probe Design Software (version 1.0; Idaho 
Technology). The primers used are listed in annex II/ Table 1. Real-time PCR was 
performed with the LightCycler-FastStart DNA MasterSYBR Green I Kitin a Light Cycler 
instrument (Roche Diagnostics). After 10 min of preincubation at 94°C, 40 cycles were 
performed with the following conditions: 94°C fór 10 s, 55-60°C fór 10 s, and 72°C fór 20 
s. Fór relatíve quantitation, a calibration line was generated from the real-time PCR data of
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1 : 1, 1 : 10, 1 : 50, or 1 : 100 dilutions of mock-infected U937 cDNA. Duplieates of the 
1 : 10  dilution of the tested cDNAs were compared with the calibration line, and the relatíve 
amounts of cDNAs were calculated by the Light Cycler analysis 3.01 software. Samples 
were standardized by using the methyl-CpG binding domain protein 4 gene, which did nőt 
change substantially in either the C. pneumoniae- or mock-infected U937 cells, as 
measured by the cDNA arravs.
3.10 Validation o f  cDNA array results by flow  cytometry.
U937 cells were infected with C. pneumoniae at a multiplicity of 4 IFU/cell; control 
cells were mock infected. Infected and mock-infected cells were collected 48 h after 
infection. Cells were preincubated with normál mouse serum, stained with FITC-labeled 
mouse anti-human CD44 or CD58 antibodv and their appropriate isotype Controls (BD 
Pharmingen), and analvzed within 30 min with an EPICS XL flow cytometer (Beckman- 
Coulter).
3.11 Chlamydia strains fó r  epithelial cell line infection andphosphoproteome analysis
C. irachomatis serovar A strain Har-13, B strain TW-5/OT, Ba strain AP-2/OT, C 
strain TW-3/OT, D strain UW-3/CX, E strain E/Bour. F strain lC/Cal-3, G strain UW- 
524/CX, H strain UW-4/CX, Li strain 440/BU, Lj strain 434/BU, L3 strain 404/BU, C. 
muridarum strain Nigg, C. pneumoniae strain AR-39, and C. caviae strain GPIC were 
propagated in HeLa 229 cells. Infectious EB were purified by density gradient 
centrifugádon, and infection-forming units (IFU) were determined as described previously 
(Caldwell, Kromhout et al. 1981).
3.12 Chlamydial infection o f  HeLa 229 and BM12.4 humán and mouse epithelial cell 
lines.
HeLa 229 cells were grown in Dulbecco modifíed Eagle médium supplemented with
10% fetal bovine serum (DMEM-10) at 37°C in 5% CO2. Cells were seeded intő 24-well 
tissue culture plates at a density of 5 * 105 cells per ml in DMEM-10, DMEM-10 
containing rifampin (1 ag/ml), or emetin (1 jxg/ml) and then incubated fór 24 h at 37°C.
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BM12.4 primary murine oviduct epithelial cells were seeded identically except that they 
were propagated in 1:1 DMEM-10:F12K (Sigma) médium suppiemented with humán 
recombinant FGF-7, as described previously (Johnson 2004). Ce!l monolayers were 
ineubated on ice fór 15 min, washed twice with 4°C Hanks balanced salt solution 
suppiemented with 10 mM HEPES (FFBSS), and ineubated on ice in 45 pg of DEAE- 
dextran/ml in HBSS solution fór 15 min. After dextran treatment, the EBs suspended in 
sucrose phosphate glutamic acid buffer were added to the cell lavers at various 
multiplicities of infection (MOI). and the cells were ineubated at 4°C fór an additional 60 
min. To initiate EB entry, the inoculum was aspirated, the cells were washed twice with 
cold FíBSS. and the temperature was shifted to 37°C bv adding prewarmed DMEM-0% 
fetal bovine serum (DMEM-0). After temperature shift (designated time zero in 
experimental time course infections), the infected and mock-treated cells were ineubated at 
37°C in 5% CO: until protein harvest.
3.13 Western biot detection o f chlamydia-induced tyrosine, serine. and ihreonine 
phosphorylation in He La 229 and BM12.4 cells.
Totál cellular proteins from 2 x 10° infected FleLa 229 or BM12.4 cells were extracted 
in 200 pl of 2* Laemmli sample buffer suppiemented with 5% (vol/vol) 14.2 M (3- 
mercaptoethanol and denatured at 95°C fór 5 min. Proteins were separated on 10% sodium 
dodecyl sulfate (SDS)-polyacrylamide gels and blotted (100 V, 30 min) onto 0.2-pm-pore- 
size nitrocellulose membranes (Bio-Rad, Inc.). Membranes were preblocked in TBSTB (1 * 
Tris buffered saline [TBS], 0.1% Tween, 1% bovine serum albumin) solution fór 1 h at 
room temperature. Blots were ineubated with primary antiphosphotyrosine antibody 4G10 
(1:1,000: Upstate, Laké Piacid, N.Y.), antiphosphoserine antibody ab9334-100 (1:200; 
Abcam. Cambridge. Mass.), or antiphosphothreonine antibody ab9338-50 (1:200; Abcam) 
in TBSTB ovemight at 4°C. Membranes were washed three times (20 min each wash) in 
TBS suppiemented with 0.1% Tween and 5% powdered milk. Washed membranes were 
ineubated with secondary anti-mouse or anti-rabbit horseradish peroxidase-conjugated 
antibodies fór 2 h at room temperature in TBS suppiemented with 0.1% Tween and 5% 
powdered milk and then washed as described above. Proteins were detected by using the
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Phototope-HRP Western biot detection system (Cell Signaling Technology, Boston, Mass.) 
according to the manufacturer's instructions.
3.14 Direct inclusion staining and determination o f  recoverable IFU.
HeLa 229 monolayers were infected with C. trachomatis serovars (B, D. H, and L2), C. 
muridarum strain mouse pneumonitis {C.muridarum), C. pneumoniae AR-39, or C. caviae 
strain GPtC, in quadruplicate, at MOl ranging from 0.025 to 1.0, as described above fór 
protein harvest infections and then grown in DMEM-10 at 37°C in 5% CO2. After 
inclusion maturation. two wells of each infection condition were methanol fixed at 42 h 
after infection (C.muridarum, C. caviae and L2), 50 h after infection (D, H, and B). and 70 
h after infection (C. pneumoniae)-, labeled using primary antichlamydial 
lipopolvsaccharide monoclonal antibody EVI-H1 and secondary fluorescein
isothiocyanate-conjugated goat anti-mouse antibody, and photographed at *100 
magnification. To determine recoverable IFU, the two remaining wells from each 
experimental infection were scraped intő 0.5 ml of sucrose phosphate-glutamic acid buffer: 
the cells were then mechanically disrupted with glass beads, and the lysates were passed 




4.1 Aim 1. To determine the presence o f  C. pneumoniae in atherosclerotic and normál 
humán middle cerebral arteries.
4.1.1 C. pneumoniae DNA and C. pneumoniae-like structures could be detecied in 
atherosclerotic bút nőt normál humán middle cerebral arteries
The patient characteristics reviewed from the autopsy records and the nPCR results 
are listed in the annex 1 Table. C. pneumoniae DNA was amplified in 5 of the 15 
atherosclerotic samples, as demonstrated by a 206-bp DNA fragment visualized by agarose 
gél electrophoresis, whereas nőne of the 4 artériái samples from healthy trauma victims 
were nPCR positive (annex 1/ Figure l). Sequencing of nPCR fragments írom 2 of the 5 
atherosclerotic samples revealed identity to the ompA sequences obtained from the 
National Center fór Biotechnology Information (NCBI) database 
(http://www.ncbi.nlm.nih.gov). Three of the 5 nPCR-positive cases had svmptomatic 
cerebrovascular disease (cerebral infarct), whereas only 2 of the 10 nPC R-negative cases 
had symptomatic cerebrovascular disease. The direct cause of death was related to 
infectious respiratory diseases in 9 of the 15 cases; there was uniform distribution among 
nPCR-positive and -negative individuals (annex 1/ Table). TEM of intimal plaques showed 
structures resembling C. pneumoniae elementary bodies in 4 of the 5 nPCR-positive 
atherosclerotic artéria! samples (annex 11 Figure 2; Figure 1 in the thesis).
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Figure 1. A, TEM of an aggregate of dense bodies in an intimal atheromatous piaque. The very close 
accumulation o f the particles suggests an intracellular localization. The boxed area is shown in panel B. 
Bar~3.0 pm. B, Pear-shaped structures ~0.3 pm in diameter and similar to Cpneumoniae elementary bodies 
(arrows). Bar=0.3 pm. C, C pneumoniae elementary bodies (arrows) in a McCoy cell at 48 hours after 
infection. Bar=0.3 pm.
These structures had a pear-shaped appearance with a dense core (Figures 1A and 1B) and 
were ~0.3 pm in diameter, ie, similar to the size of the elementary bodies detected in 
control infected tissue culture cells (Figure IC). Nőne of the 5 nPCR-negative 
atherosclerotic samples examined by TEM exhibited C. pneumoniae-\í\íq structures.
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4.2. Aim 2. To obtain a detailed áescription o f  C. pneumoniae infection on the gene 
expression o f humán monocytes using the high-throughput DNA-chip method.
4.2.1 Detection o f C. pneumoniae protein and mRNA in the infected cells shows a 
maintained viablility o f  the hacterium in the hőst U937 cell line.
The presence of C. pneumoniae protein and mRNA in U937 cells was determined 
with monoclonal mouse anti-C. pneumoniae MOMP antibody by means of confocal 
microscopy and quantitative real-time PCR, respectively, at 0, 2, 6, 10, 24, and 48 h after 
infection. At 0 h after infection, -70%  of the cells were positive fór MOMP protein, 
displaying 1-20 small fluorescing dots of variable intensity. Mock-infected cells showed 
only dim background fluorescence (annex II/ Figure ÍZ)). Positive staining fór MOMP 
could be detected during the entire course of the experiment (annex II/ Figure 1A-C), and 
C. pneumoniae particles were found both on the surface and inside the cytoplasm of the 
infected cells (annex II/ Figure 1 A, insert), indicating the continuous presence of C. 
pneumoniae in the cells. To further investigate whether C. pneumoniae is metabolically 
active in U937 cells, real-time PCR was performed with 2 different C. pneumoniae primers. 
Expression of MOMP and GroEL genes were measured in hőst cells infected by live or 
heat-inactivated C. pneumoniae. The expression pattems of the 2 genes were relatively 
constant, showing a slight increase in transcription at 10 h after infection and a slight 
decrease in the later time points in the cells infected with viable bacteria. In contrast, in the 
cells infected with heat-inactivated bacteria, the MOMP and GroEL mRNA levels 
decreased significantly by 2 h after infection and remained at the same low level during the 
48-h time period (annex II/ Figure 1E  and ÍZ). The decrease in mRNA levels at the 0 time 
in the case of MOMP is likely due to degradation of the message pool in the heat- 
inactivated bacteria during the 45-min centrifugádon.
4.2.2 cDNA array analysis shows a signijicant impact o f  C. pneumoniae infection on the 
gene expression o f  the hőst U937 cell line.
The transcriptional responses of U937 cells to C. pneumoniae and mock infection 
were examined by cDNA array at 6 time points over a 48-h time course in 3 independent
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experiments. The cDNA array contained 2032 unique humán genes selected to include 
fiinctions relating to apoptosis, eell cvcle, eeil stress, metabolism, signaling, transcription 
regulation, inílammation, immuné response, and cardiovascular disease. To assess the 
global changes in gene expression as a fiinction of time after infection, we computed 6 t 
tests comparing expression values at individual time points in the C. pneumoniae-infected 
cells with the combined expression values fór all time points of the mock-infected cells. The 
results of these t tests are shown in annex II/ Figure 2. By using the P < .05 cutoff and by 
estimating the number of false positives, as described in Materials and Methods, we 
detected 67 differentially expressed genes at 6 h, with the numbers increasing to 184 genes 
at 10 h after infection. Interestingly. this rapid increase in signifícantly changed genes 
paralleled the increases in C. pneumoniae MOMP and GroEL mRNA expression, which 
alsó peaks at 10 h after infection (annex II/ Figure lE and \F). At 24 and 48 h after 
infection, the number of differentially expressed genes {P < .05) stabilized at M 00 (20%) of 
all the genes on the array. The seventh curve on the figure, a paired t test between all the 
infected and mock-infected time point data, shows the same number of differentially 
expressed genes, indicating that the majority of the changes occurred at the later time 
points. After application of additional filters (see Materials and Methods) to the genes that 
had a P < .05 in any of the 7 t tests described above, we fínd 67 signifícantly up-regulated 
genes and 61 signifícantly down-regulated genes.
4.2.3 Time-course analysis o f  the signifícantly up- and down-regulated hőst genes in 
response to C. pneumoniae infection reveals nine major gene expression clusters.
When the 128 significant genes were subjected to &-means clustering, 6 clusters o f up- 
regulated and 3 clusters of down-regulated genes were obtained (annex 2/ Figure 3A and 
3B; Figure 2A and 2B in the thesis).
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M. Ckjster 6 (n » 12)
Cluslei Gune u n t Tünetiem Symbol Ratio
S GR03 oncogene (MIP2B) Cytokine GR03 479 E
2 smal inducible cytokine A3 (MIP1A) Cytokine SCYA3 291.7
E pro piatelet basic protein Cytokine PPBP 164 8
5 matnx metalloproteinase 10 Tissue re modelling MMP10 116.1
6 matnx metalloproteinase 3 Tissue re modelling MMP3 630
2 GR01 oncogene Cytokine GR01 574
4 email inducible cytokine A2 (MCP1) Cytokine SCYA2 8D3
3 small inducible cytokine A4 (MIP18) Cytokine SCYA4 447
5 interleukin 1. béta Cytokine L1B 407
6 small inducible cytokine A1.1-309 Cytokine SCYA1 232
E serpin B7 Tissue remodelknq SERPINB7 179
1 NF-kappaB inhibitor alpha Transciiption NFKBIA 154
1 tumor necrosis factor (TNF supeitamily, member 2) Cytokine TNF 154
2 regulator of G  protein siqnaUinq 1 Stgnal transductun RGS1 11.0
3 tumor necrosis factor. aiphe-induced protein B CSA* TNFAW 11 6
2 diphlhena lórin receptor (HBEGF) Cytokine DTR 11 5
4 Homo sapiens epithekal membráné protein 1 (EMPH CSA EMP1 10.9
5 fatty acid bmdinq protein 4. adipocyte Cardiovascuiar FABP4 10 3
2 ELK3. ETS-domam protein (SRF accessory protein 2) Transciiption ELK3 10 2
5 plasminogen activalor. urokinase Cardioyascutar PLAU 101
5 qlycerol kinase Melabolism GK 9.4
5 smal inducible cytokine AB (MCP2) Cytokine SCYAfl 92
4 transmembrane protein 2 CSA TMEM2 76
E matnr metalloproteinase 12 (macrophage elastase) Tissue lemodetkng MMP12 73
2 CCAAT/enhancer binding protein (C/EBP). béta Transciiption CEBPB 7.1
1 tumor necrosis factor. alphe-induced protein 3 Sípnál transduction TNFAIP3 7 0
5 Protooncogene SRC, Rous sarcoma Sípnál transduction SRC 50
fi C044 antigén CSA C044 5.0
1 jun B proto-oncoqene Transcnption JUNB 47
5 chemokme (C-C motit) receptor 1 CSA CCR1 4.7
3 tumor necrosis factor fliqand) supeitamily, member 7 CSA TNFSF7 4.3
3 annexin A1 Cardiovasciiar ANXA1 4.2
2 coaqulation factor V (proaccelenn. latule factor) Cardiovascuiar F5 4 2
4 TRAF farrulY membor-associaled NFKB actnator Sípnál transduction TANK 4.1
B E = a Gene nem e Funcdae
7 u-myb myeloblaslosis ural oncogene homolog (awian) T ranscnption MYB -264
8 MCM7 mmichromosome maintenance deficient 7 DNA metaboksm MCM7 -21.2
9 similat 10 RIKEN cDNA 2610036L13 other !.V«M1A':'ÍBTCT
7 UM domain only 2 (ihombotin-hke 1) Cell Cycle ILM02 -112
8 IMP (inosine monophosphate) dehydrogenase 2 Metabolism IMPOH2 -110
7 ribonuclease. RNase A  íamjly. 2 RNA metabolism 101
9 knesm-kke 5 tiratotic kinesin-like protein 1) Cell Cycle 7 6
7 phosphonbosylaminoimidazole carboxylase meidDOiibm PAICS -7 2
8 heterogeneous nuclear nbonucleoprotein A1 RNA metaboksm HNRPA1 -7.1
9 cé l dmsion cycle 2SB Call Cvcla CDC25B -65
8 small nuclear nbonucleoprotein D1 polypeptide (16kD) RNA metabolism SNRPD1 -63
7 matnx Gla protein other MGP -60
7 repkcatun factor C (activator 1) 1 (145kD) DNA metaboksm RFC1 -55
7 ligásé 1. DMA. ATP dependent DNA metabolism UG1 -5.4
9 kmesm-like 6 Call Cycle KNSLE -4 8
8 heat shock 90k0 protein 1. béta Chaperone HSPCB -46
7 RAB32. member RAS oncogene farmlv other RAB32 -46
9 nuclear transport factor 2 Metabolism NTF2 -45
8 sex comb on midleg homokig 1 Transcnption SCMH1 -42
9 polo-like kinase (Drosophila) Cell Cycle PLK -40
8 interferon consensus sequence binding protein 1 Transcnption ICS8P1 -40
8 hypoxanthine phosphonbosyltransferase 1 Metabolism HPRT1 -39
8 protein kinass. DNA-actiwated. catalytic polypeptide DNA metabolism PRKDC -39
7 phosphoribosyl pyrophosphate amidotransferas* Metabolism PPAT -39
8 nucleophosmin other NPM1 -3 8
9 FK506 binding protein 1A (12kD) Cytosk etetőn FkBP1A -37
7 chromosome 12 open readinq Iramé 8 Metabolism C12orB -36
7 serine/arqinme repetitne mátrix 1 RNA metabolism SRRM1 -3.6
8 Hs eukaryotic transtation elongation factor 2 Metabolism EEF2 -36
7 Nucleoprotein TPR Metabolism TPR -3.5
8 acetyl-Coenzyme A acetyttransferase 2 Metabolism ACAT2 -3 5
8 prohlbím Cell Cycle PHB -34
9 cyclm dependent knase 2 Cell Cycle CDK2 -34
8 mitochondnal ribosomal protein S35 Metabolism MRPS35 -33
9 retinobiasloma binding protein 4 DNA metaboksm RBBP4 -32
24
Figure 2. Changes in gene expression in U937 cells in response to Chlamydia pneumoniae infection. 
Up-regulated (AJ and down-reguiated (3) expression profiles of gene clusters in C. pneumoniae-infected cells 
over the 6 time points (0,2, 6, 10, 24, and 48 h). Gene expression dara were normalized, and the r-scores were 
used fór A-means clustering. /fc-means clustering allocates genes intő one of the A-clusters according to 
correlation between the average profilé in each cluster and the gene profile. A negative z-score does nőt 
necessarily indicate that the genes are down-regulated, bút rather that the expression at the particular time 
point is lower than the average expression. The black. red, and green curves represent the mean, mean ± SD, 
and mean - SD of the z-scores of gene expressions related to the particular cluster. Genes that show at least 4- 
fold up-regulation (C) and at least 3-fold down-regulation (D). The ratio reported is calculated with the 
average normalized signal intensities of the 3 independent experiments at the time point when the maximum 
fold of up-or down-regulation was measured. CSA, cell surface molecule.
From the 6 up-regulated gene clusters, cluster 1 contained genes with an early and transient 
up-regulation profilé. Important transcriptional regulators—including JunB, NF-kB I, NF- 
kb inhibitor-a (I-tcBa), CCAAT/enhancer binding protein-P (CEBPB), and 
proinflammatory cytokine tumor necrosis factor (TNF)-a were included among the 7 genes 
that were rapid responders. Clusters 2 and 4 included genes that were up-regulated early (2- 
6 h after infection) and then remained at relatively the same level during the course of 
infection. These clusters contained cell-surface antigens, such as CD82 and CD58. that are 
important fór antigén presentation and the first wave of chemokines and chemokine 
receptors, including MCP-1, growth-related oncogene (G RO )-l, M lP-la, and CC 
chemokine receptor like-2. Other genes with a potential role in atherosclerosis, such as the 
diphtheria toxin receptor (heparin-binding EGF-like growth factor [HBEGF]), Niemann- 
Pick disease type C l, and coagulation factor 5, were alsó found in the clusters. Cluster 3 
contained genes that were transiently up-regulated, peaking 6-10 h after infection, including 
anti-inflammatory genes such as annexin A1 and TNF-a-induced protein 6 (TNFAIP6), a 
member of the hyaluronan binding family that includes CD44 (Lee, Wisniewski et al. 
1992). It is noteworthy that the expression pattem of this gene cluster parallels that of the C. 
pneumoniae MOMP and GroEL genes (annex II/ Figure 1£ and 1/). Clusters 5 and 6 
contain genes peaking only at 24 and 48 h after infection. These 2 groups include a second 
wave of up-regulated cytokines and receptors related to chemotaxis, attachment, and
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activation, including IL -ip , MC'P-2, 1-309 (chemokine receptor CCR8 ligand), chemokine 
receptor-1, G protein-coupled receptor 30, CD44. and integrin-aX. Other genes possibly 
related to atherosclerosis disease. such as the tissue remodeling genes MMP-3, MMP-10, 
MMP-12, and proplatelet basic protein (PPBP), the vasoconstrictor endothelin (E T)-l, and 
lipid metabolism genes, including fatty acid binding protein (FABP)-4 and glycerol kinase, 
were alsó in these laté responder clusters.
Clusters 7. 8, and 9 contained genes with down-regulated expression levels detected at 2, 
6, and 10 h altér infection, respectively. The down-regulated gene sets were functionally 
rather uniform and primarily included genes related to DNA and RNA metabolism, cell- 
cycle regulation, and growth.
Regarding the fold changes of gene expression in C. pneumoniae-infectQd U937 
cells, the most highly up-regulated genes were related to chemotaxis and inflammation. 
GROG (MIP-2P) exhibited a 480-fold change, small-inducible cytokine A3 (M lP-la) 
exhibited a 290-fold change, and PPBP exhibited a 165-fold change. Twotissue-remodeling 
genes, MMP-10 and MMP-3, were alsó highly up-regulated (116- and 63-fold. respectively; 
Figure 2Q . The most highly down-regulated gene is the proto-oncogene v-myb (26-fold 
change; Figure 2D), which induces proiiferation and differentiation of hematopoietic 
precursors (Karafiat, Dvorakova et al. 2001). The degree to which gene expression was 
down-regulated was lower in generál; only 6 genes were > 10-fold down-regulated, 
compared with the 20 genes that were up-regulated by >10-fold.
To highlight the potential role of C. pneumoniae in inflammation and atherosclerosis, a 
subset of genes with functions related to the innate or acquired immuné response and genes 
associated with atherosclerosis were divided intő functional groups and reclustered by 









































































Figure 3. Tree views of differentially expressed genes related to acute and chronic inflammation and 
vascular pathologic abnormaiities. The tree views were generated by means of normalized gene expression 
values (z-scores). Each row represents a single gene. Red squares, genes that are overexpressed; green 
squares, genes that are underexpressed, compared with the onchanged expression levels <black). The columns 
represent the 0-, 2-, 6-, 10-, 24-, and 48-h time points. The ratio reported is calculated by using the average 
normalized signal intensities of the 3 índependent experiments at the time point when the maximum fold of 
up- or down-regulation was measured.
4.2.4 The índependent real-time quantitadve PCR andflow-cytometry methods confirm 
the cDNA array data.
To validate the cDNA array data, real-time PCR was performed on 9 genes with 
different levels of up- and down-regulation in the C. pneumoniae-infected cells, as 
determined by cDNA arrays. By means o f cDNA reverse transcribed from aRNA, the real- 
time PCR results confirmed the cDNA array data in each ofthe 9 cases and gave a ratio of 
over- or underexpression either similar to or greater than that determined in the array 
experiments (annex 11/ Table 2). This was alsó true when nonamplified RNA was used 
supporting the linearityof the amplifícation procedure used (annex II/ Table 2, columns 2 
and 3). The signifícantly greater levels of change in expression of IL-ip, MMP-10, and 
PPBP genes detected by PCR could result from nonspeciíic array cross-hybridization.
The expression profiles of NF-icBl and its inhibitor, I-icBa, were alsó assayed by real- 
time PCR. Expression levels were determined fór each time point from the C. pneumoniae- 
and mock-infected cells. As shown in annex II/ Figure 5A and 5B, the real-time PCR and 
cDNA array methods resulted in very similar curves, again validating the cDNA array data.
The array data indicated that the message levels fór the cell-surface molecules CD44 and 
CD58 had a 3.8- and 3.4-fold increase, respectively, in the C. pneumoniae-infected cells 48 
h after infection. CD44 and CD58 antigén levels were foundto be increased 3.2-and 2-fold 
in the infected cells, as detected by flow cytometry (annex II/ Figure 6.A and 6B). In 
addition to confirming the cDNA array results, these data alsó show that the mRNA and 
protein levels changed similarly in these 2 cases.
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4.3. To determine whether there are dijferences between the major chlamydial strains 
during the early interaction o f  the hőst cell, particularly comparing the chlamydia-induced 
early tvrosine-phosphorylation Cascade.
4.3.1 C. trachomatis serovar D infection induces rapid, protein synthesis-independent, 
protein tvrosine phosphorylation in HeLa 229 cells in vitro.
To determine whether the humán mucosal pathogen C. trachomatis serovar D 
induces protein tyrosine phosphorylation, HeLa 229 cells were infected at MOI ranging 
from 0 to 100, and totál cellular proteins were harvested 1 h postinfection (p.i.). Extracted 
proteins were separated by SDS-polyacrylamide gél electrophoresis (PAGE), blotted to 
nitrocellulose, and probed with the antiphosphotyrosine-specifíc monoclonal antibody 
4G10 (annex III/ Fig. 1A). Serovar D infection induced protein tyrosine phosphorylation 
in HeLa 229 cells in an MOI (multiplicity of infection)-dependent fashion, with the pattem 
of phosphorylation being most similar to that previously reported fór C. trachomatis L2 
indicating that the tyrosine phosphorylation induction is a generál phenomena of C. 
trachomatis infection. Infection-induced tyrosine-phosphorylated proteins included an 
intensely labeled complex of proteins migrating with apparent molecular sizes ranging 
from 70 to 75 kDa (70-kDa complex) induced at MOI of > 10, presumably corresponding 
to the 64- to 68-kDa complex of proteins reported earlier (Birkelund, Johnsen et al. 1994) 
in association with C. trachomatis Li infection. A single tyrosine-phosphorylated protein of 
-110 kDa, corresponding to the 98-kDa h 2 protein reported earlier (Birkelund, Johnsen et 
ai. 1994), was induced at the same MOI bút was less intensely labeled than the 70-kDa 
complex. Because both the 70-kDa complex and the 110-kDa protein were easily 
visualized at MOI of 50, this inoculum was used fór subsequent kinetic studies. To 
determine the kinetics of tyrosine phosphorylation, HeLa 229 cells were infected with C. 
trachomatis serovar D at an MOI of 50, and totál proteins were harvested at various 
intervals between 0 and 60 min p.i. Tyrosine phosphorylation of the 70-kDa complex was 
detectable within 10 min of infection (annex III/ Fig. 1B). The labeling intensity increased 
progressively during the 1-h time course. As previously described fór L2-induced protein
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tyrosine phosphorylation (Birkelund, Johnsen et al. 1994). the kinetics. the pattem and 
intensity o f tvrosine-phosphorylated proteins were essentially identical in the presence of 
hőst (emetin) or bacteriai (rifampin) inhibitors of protein synthesis (annex III/ Fig. IC and 
D).
4.3.2 Chlamydial induction o f  protein tyrosine phosphorylation is pathobiotype specific.
Our investigation intő phosphorylation induced by C. trachomatis serovar D 
suggested that the pattéra of chlamydia-induced protein tyrosine phosphorylation was 
similar, bút nőt identical, to that previously reported fór Li (Birkelund, Johnsen et al.
1994). Considering the data in toto, we suspected that phosphorylation might correiate with 
early infection events that differentiate chlamydial biology in vivő. To test this hypothesis, 
HeLa 229 cells were infected with C. trachomatis trachoma biovars (A, B, Ba, C, D, E, F, 
G, and H), C. trachomatis LGV biovars (Ls, L2, and L3), the humán respiratory pathogen C. 
pneumoniae AR-39. and the rodent pathogens C. muridarum and C. caviae GPIC at MOI 
of 50 and harvested 1 h p.i. Profiles of protein tyrosine phosphorylation induced by 
chlamydial infection feli intő four distinct groups and, surprisingly, these groups sorted the 
infecting strains intő established in vivő pathobiotypes (annex III/ Figure 2A; Figure 4A in 
the thesis). First, the 110-kDa protein (Figure 4B, protein numbered 1) was induced by all 
C. trachomatis strains, including C.muridarum. In contrast, neither the more distantly 
related humán pathogen C. pneumoniae AR-39 nor C. caviae strain GPIC induced 
phosphorylation of any proteins above background (mock infection) levels (annex III/ 
Figure 2A to C; Figure 4A to C in the thesis). In order to exclude the possibility that the 
slower growing C. pneumoniae AR-39 induces tyrosine phosphorylation later, we extended 
our tyrosine phosphorylation screen to 2, 4, and 8 h after infection. Both C. pneumoniae 
AR-39 and C. caviae GPIC strains failed to índuce any detectable tyrosine phosphorylation 
during this time period (annex III/ Figure 2D; Figure 4D in the thesis).
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biovar
Figure 4. Induction o f protein tyrosine phosphorylation by chlamydial infection. (A) HeLa 229 cells were 
infected with the C. trachomatis trachoma biovar serovars (A to H), LGV biovar serovars (Li, L2 , and L3 ), C. 
muridarum strain Nigg (C.muridarum), C. pneumoniae AR-39, or C. caviae GPIC. The most predominant 
regions of tyrosine phosphorylation are marked with an asterisk. (B) Composite biot from panel A showing
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examples of each of the four prototypic protein tyrosine profiles induced by C. trachomatis serovar H 
(trachoma), C. trachomatis LGV biovar L2 (lymphogranuloma), C. muridarum, and C. pneumoniae AR-39, 
Major chlamydia-induced tyrosine phosphorylated proteins are indicated by large arrows and numbers; minor 
proteins are indicated by small arrows. (C) Magnifíed view of the 65-to 90-kDa region of the biot in panel B. 
(D) Tyrosine phosphorylation screen at later time points of chlamvdial infection shows that C. pneumoniae 
and C. caviae GPIC failed to induce tyrosine phosphorylation at 2,4, and 8 h after infection.
More interestinglv, the pattem of tyrosine-phosphorylated proteins in the 70-kDa complex 
strictly sorted the C. trachomatis strains intő trachoma and LGV biovars. C. trachomatis 
trachoma biovars, mucosa-tropic pathogens in vivő, induced tyrosine phosphorylation of 
three major proteins ranging from ca. 75 to 70 kDa (annex III/ Figure 2B-C; Figure 4B and 
C, proteins 4, 5, and 6 in the thesis). In contrast. C. trachomatis LGV biovars, nonmucosal 
lymphotropic pathogens in vivő, induced phosphorylation of the two smailer proteins in the 
70-kDa complex (annex III/ Figure 2B-C; Figure 4B and C, proteins 5 and 6 in the thesis) 
bút failed to phosphorylate the largest of the three proteins (annex III/ Figure 2B-C; Figure 
4B and C, protein 4 in the thesis) induced by trachoma isolates. C. muridarum, a more 
distant relatíve of the human-adapted strains restricted in vivő to the murine hőst, triggered 
phosphorylation of a complex of proteins in the rangé of 75 to 85 kDa (annex III/ Figure 
2B-C; Figure 4B and C proteins 2 and 3 in the thesis), clearlv distinct from all humán C. 
trachomatis strains. Strain-specific protein tyrosine phosphorylation pattems were distinct 
and conserved between independent experiments performed at multiple MOI (data nőt 
shown). Further, differential induction of protein phosphorylation was restricted to tyrosine 
residues, since all infected samples, as well as mock samples, yielded similar pattems of 
serine and threonine protein phosphorylation in parallel immunoblots performed with 
antiphosphothreonine- and aníiphosphoserine-specific antibodies (data nőt shown).
4.3.3. Chlamvdial infection efficiency is nőt the source o f  the observed tyrosine 
phosphorylation difference in HeLa 229 cells.
Because chlamydial strain-specific pattems of protein tyrosine phosphorylation 
were repeatable and observed at different MOI in independent experiments, we reasoned 
that these differences might reflect differential sensitivity of the hőst HeLa 229 cells to 
various chlamydial strains. To test this, HeLa 229 cells were infected at different MOI with
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the identical chlamydial stocks used in the tyrosine phosphorylation experiments. Infected 
cél Is were fixed and chlamydial inclusions visualized by immunofluorescence microscopy 
(annex III/ Figure 3A). In a parallel experiment, inclusions were allowed to mature, and 
recoverable IFU derived írom infections performed at different iVÍOI were determined 
(annex III/ Figure 3B). Both direct inclusion staining and recoverable IFU counts 
confirmed that essentially equivalent doses of viable chlamydial inoculum were used in 
determinations of protein tyrosine phosphorylation and that C. pneumoniae AR-39 and C. 
cavie GPIC complete their developmental cycles in HeLa 229 hőst cells. This result 
strongly argues that the observed differences in phosphorylation profi les reflect 
fundamental biologic differences between chlamydial strains and that the lack of tyrosine 
phosphorylation in the case of C. pneumoniae and C. caviae was nőt due to the inefficient 
infection.
4.3.4. Chlamydia strains induce a highly similar tyrosine phosphorylation in humán and 
mouse epithelial cells.
Whether tyrosine-phosphorylated proteins induced by chlamydial infection are of 
hőst or bacterial origin remains controversial; data implicating individual C. trachomatis 
serovar L?-induced tyrosine-phosphorylated proteins deriving from both sources have been 
reported (Birkelund, Johnsen et al. 1994; Fawaz. van Ooij et al. 1997; Clifton, Fields et al. 
2004). In the absence of direct identification of each of these proteins, we reasoned that 
infection of different hőst cells might suggest their origin. To test this, we infected HeLa 
229 and BM12.4 primary murine oviduct epithelial cells (Johnson 2004) with chlamydial 
strains at an MOl of 50 and immunoblotted whole-cell lysates harvested 1 h p.i. with 4G10 
(annex III/ Figure 4). Surprisingly, the infection and strain-specific tyrosine- 
phosphorylated protein profiles induced by chlamydial infection were nearly identical 
between the humán and mouse cells. ín contrast to the conserved infection-induced 
tyrosine-phosphorylated protein profiles in the three cell lines, the pattem of background 
4G10 reactivity differed markedly (annex III/ Figure 4). Therefore, the results indicate that 
the trachoma-induced 70-kDa complex proteins and the C. muridarum 75- to 85-kJDa 
complex proteins are of chlamydial origin, however; we cannot exclude the possibility that
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four different chlamydia strains induced the phosphorvlation of a cohort of conserved hőst 
cell proteins with very similar sizes in humán and murine cells.
Discussion
5.1 C. pneumoniae has been detected in atherosclerotic tissues at different sites of 
the vascular svstem, including the carotid and coronary arteries, the aortic valves, the aorta, 
and arteries in the lower extremities. A summary of the results írom 23 studies indicated 
that C. pneumoniae was detected in 52% (257 o f 497) of diseased arteries and in 5% of 
controi vessels by immunohistochemistry or PCR.(Campbell, Kuo et ai. 1998) We extended 
the molecular epidemiology search to the medically important middle cerebral artery region 
that is frequently related to stroke. We detected the presence of C. pneumoniae DNA in 
33% of the diseased middle cerebral artériái samples and in nőne of the Controls by nPCR. 
A review of the autopsy records revealed cerebral infarct in 3 of the 5 nPCR-positive cases, 
in contrast with oniy 2 of the 10 nPCR-negative cases. However, the small number o f cases 
did nőt permit a statistical comparison. A further limitation of the present study is that the 
detectability of C. pneumoniae DNA in the cerebrovascular vessels might be reiated to age. 
Because of the vounger age of the controi individuals and the small numbers of nPCR- 
positiveand -negative cases, statistical comparison is nőt helpfiil, and this possibility cannot 
be excluded. The present study has demonstrated the presence of C. pneumoniae DNA in 
somé atherosclerotic samples from middle cerebral arteries, bút further studies appear 
desirable to test fór the presence of this organism in these vessels in relation to age and the 
occurrence of symptomatic cerebrovascular diseases. Because there was no difference in 
the incidence of respiratory diseases as the direct cause of death among the nPCR-positive 
and -negative cases, it is improbable that C. pneumoniae nPCR positivity was secondary to 
the infectious diseases, which are rather considered to be terminal-stage diseases that 
developed a few days before death.
The detection of pear-shaped structures in C. pneumoniae nPCR-positive 
atherosclerotic samples by TEM suggests that nőt only bacterial DNA bút the complete 
pathogen was alsó present in the intimal plaque.
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A prominent aggregation of dense particles indicates an intracellular accumulation 
of these structures. The additional presence of this microorganism extracellularly suggests 
either spontaneous autolysis of the cells followed by bacterial ílow intő the extracellular 
mátrix or the accumulation o f these pathogens outside the cell during a certain stage oftheir 
life cycle. C. pneumoniae organisms were earlier found by electron microscopy in cells and 
interstitially in atherosclerotic lesions of the aorta or carotid or coronarv arteries, bút nőt in 
the adjacent nonatherosclerotic tissue.(Taylor-Robinson and Thomas 2000)
The middle cerebral arteries are important sites of cerebral thrombosis. The 
presence of C. pneumoniae in the atheromatous plaques of the middle cerebral artery does 
nőt necessarilv mean that the organism is a causative agent of the disease; it rather raises 
the possibilitv of a role fór this bacterium in the pathogenic process. Such a role would 
point to the value of antibiotic treatment as a means of attenuating cerebrovascular diseases 
relating to C. pneumoniae. Tests on a larger number of cases and age- and sex-matched 
Controls appear warranted, extending to the C. pneumoniae serostatus and the presence of 
C. pneumoniae DNA and antigens in vessels other than middle cerebral arteries in the same 
subjects.
5.2 We have examined the effects of C. pneumoniae infection on global gene 
expression in U937 monocytic cells. Our aim was to determine whether the changes in gene 
expression that occur support the hypothesis that C. pneumoniae-infected monocytes can 
contribute to the development of atherosclerosis and other diseases associated with 
inflammation. Other studies that used the same U937 cell line and C. pneumoniae AR-39 
strain that we used showed that bacterial viability, bút probably nőt replication, can be 
detected during the initial 48-h time period after infection that we studied (Gaydos, 
Summersgill et al. 1996; Lin, Campbell et al. 2000; Puolakkainen, Campbell et al. 2003). 
Our immunofluorescent experiments showed the continuous presence of C. pneumoniae 
inside and on the surface of the U937 cells. In addition. real-time PCR experiments 
demonstrated that, although bacterial mRNA levels decreased precipitously in cells treated 
with heat-killed bacteria, mRNA levels were maintained around the steady-state level in 
cells treated with viable C. pneumoniae. ít is possibie that somé of the effects we have 
recognized are the result of infection. and others are the result of interaction and activation 
of the hőst that do nőt necessarilv require the presence of viable bacteria. Although studies
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with primary ceJls wil) be required to verify our observations in U937 cells, many of the 
effects on gene expression that we observed in the U937 model were consistent with what is 
known about monocyte activation.
Our cDNA array results show that infection of U937 cells with C. pneumoniae has 
far-reaching effects on gene transcription within the 48-h time period we have monitored. 
Signifícant changes in gene expression were detected in at least 8% ofthe 1500 expressed 
genes. Expression levels of 12 of the genes were confirmed either by quantitative real-time 
PCR or by flow cytometry. In every case, the direction of change detected by the array data 
was confirmed by our secondary analyses. We detected several classes of genes that were 
up- or down-regulated soon after infection. Fór the most part, down-regulated gene 
expression was detected early and was sustained throughout the 48-h study period. Down- 
regulated genes were less diverse in function and, in generál, were associated with RNA 
and DNA metabolism. cytoskeleton, cell-cycle regulation, and chromosome maintenance. 
The most highly down-regulated genes, the Myb oncogene and minichromosome 
maintenance protein (MCM) 7, are both involved with DNA repiication and cell 
proliferation, Myb at the level of transcription (Karafiat, Dvorakova et al. 2001) and MCM7 
at the level of chromosome stability (Labib, Kearsey et al. 2001). The consistent down- 
regulation of genes related to cell division may be a reílection ofthe generál abatement of 
cell cycle progression and the associated metabolic pathways. A similar effect was 
previously observed in the THP1 monocytic cell line after C. pneumoniae infection 
(Yamaguchi. Haranaga et al. 2002).
Genes rapidly up-regulated after infection with C. pneumoniae includeNF-KBl and 
its inhibitor 1-icBa, junB, CEBPB, and the important proinflammatory cytokine TNF-a. 
Expression of each of these early genes has been linked to the induction of the expression of 
many of the genes associated with inflammation that we find up-regulated at later times, 
including NF-xB-regulated ÍL-1, ÍL-6, TNF-a, MCP-1, MMP-3 (Makarov 2000), junB 
(API complex)-regulated HBEGF (Park, Adam et al. 1999), MMP-3 (Liacini, Sylvester et 
al. 2002), and CEBPB-regulated M lP-la, M IP-lp, granulocyte colony-stimulating factor. 
and MCP-1 (Ramji and Foka 2002). TNF-a gene expression is both reguiated by and can 
induce NF-kB (Makarov 2000). TNF-a can alsó induce expression of IL-1, IL-6, 
plasminogen activator urokinase, MMP, and other molecules, such as TNFAIP6 and
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TNFAIP3. Message levels foreach of íhese genes were increased in our infected cultures at 
later time points. This could be due, in large part, to the effects of TNF-a on NF-kB 
aetivation.
Several inflammation-reiated genes were up-reguiated in response to C. pneumoniae 
infection, including chemokines that exhibited high levels of up-regulation (9-480-fold). 
Expression of these chemokines by monocytes in vivő could trigger the extravasation and 
local accumulation and aetivation of neutrophiis, monocytes, and lymphocytes. Chemokine 
expression profiles in the infected cells were similar fór the fírst 24 h after infection. 
Fíowever. although the expression of several chemokines that are chemotactic fór 
neutrophiis decreased by 48 h after infection, 2 monocyte-lymphocyte chemokines. 1-309 (T 
cell activator 3) and MCP-2, remained elevated (Figure 3A, clusters 5 and 6). It is alsó 
noteworthy that, among the 3 chemokine receptors, we found up-regulated expression of 
CCR1, a receptor fór MCP-2, which remained elevated at 48 h (Figure 3A, cluster 5). This 
suggests that a long-term effect of C. pneumoniae infection of monocytes could be the 
expression of chemokines thatfacilitate mononuclear cell infiltration.
ín addition to the induction of inflammation-associated chemokines, C. pneumoniae 
alsó induced expression of genes fór cell-surface molecules that could contribute to the 
inílammatory process, including CD44, TNFA1P6, and integrin-aX. The expression of 
CD44 has been shown to contribute to several types of inflammation-reiated diseases, such 
as arthritis, experimental encephalomyelitis, colitis, and atherosclerosis (Pure and Cuff 
2001). Induction of the hyaluronan receptor CD44 due to C. pneumoniae infection has nőt 
previously been demonstrated. A second hyaluronan receptor, TNFAIP6, was alsó highly 
up-regulated in the present study. The function of TNFAIP6 is less well understood, bút its 
expression has been linked to anti-inflammatory responses (Bárdos, Kamath et al. 2001). 
The expression pattems of these 2 hyaluron receptors were very different. TNFAIP6 
expression peaked early and then decreased to baseline level by 48 h after infection (Figure
3,4, cluster 3). In contrast, the CD44 mRNA levels increased slowly, and, at 48 h after 
infection, message levels persisted at their highest level (Figure 3A, cluster 6). These data 
suggest that, early in infection, the presence of C. pneumoniae can induce nőt just pro- bút 
alsó anti-inflammatory genes, as evidenced nőt only by the expression of TNFAIP6, bút 
alsó by the expression other anti-inflammatory genes, including annexin A 1. This response
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appears to be transitory and is eventually superseded by the expression of a variety of 
proinflammatory chemokines and cvtokines and inflammation-associated cell surface 
markers, including CD44 and integrin-aX.
In generál, many of the up-regulated genes were associated with clusters 2 and 5, 
and particularly 4 and 6, where a majoritv of the gene expression levels remained at high 
levels or were still increasing at 48 h. These genes could contribute to a long-term effect on 
monocytes-macrophage gene expression due to C. pneumoniae infection.
A fundamental role fór different proinflammatorv molecules, such as monocvte 
chemokines, in the development of chronic inflammatory diseases, such as atherosclerosis 
or multiple sclerosis, has been described elsewhere (McManus, Berman et al. 1998; 
Gosling, Slaymaker et al. 1999). The fact that we find chemokines such as MCP-1 to be 
induced by C. pneumoniae supports suggestions that C. pneumoniae-infected monocytes 
may contribute to these inflammatory processes. Continuous tissue remodeling, including 
local mátrix degradation and fibroblast and smooth-muscle cell proliferation, are alsó 
characteristic features of atherosclerosis. We alsó found 3 MMPs—MMP-3, MMP-10, and 
MMP-12—to be highly up-regulated (63-, 116-. and 7.3-fold. respectively). Additionaí up- 
regulated genes include HBEGF and P-thromboglobulin. HBEGF has been shown to 
induce proliferation of smooth-muscle cells (Higashiyama, Abraham et al. 1991); p- 
thromboglobulin (part of the up-regulated PPBP) is chemotactic fór fíbroblasts (Senior, 
Griffín et al. 1983). HBEGF has alsó been detected in macrophages in atherosclerotic 
tissues (Reape, Wilson et al. 1997) and in C. pneumoniae-'mfected endothelial cells 
(Coombes and Mahony 2001). We alsó found that important members of the coagulation 
cascade. coagulation factor V and plasminogen activator urokinase, were up-regulated affér 
C. pneumoniae infection, indicating that the local coagulation cascade could alsó be 
influenced by C. pneumoniae-infected monocytes. Other C. pneumoniae-máucQá genes 
that could promote atherosclerosis include those involved in either fatty acid or cholesterol 
traffícking, such as FABP-4 and Niemann-Pick disease type C l. The overexpression of 
genes responsible fór lipid accumulation could be a defensive response o f the hőst cell to 
infection, because the growth of C. pneumoniae is inhibited by high intracellular lipid levels 
(Blessing, Kuo et al. 2002). However, the lipid accumulation in macrophages alsó leads to 
foam-cell formation, which is an early event in the development of atherosclerosis. Finallv,
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we fínd thatthe gene fór ahighiy potent vasoconstrictor, ET-1, is up-regulated (3.5-fold) in 
infected cells. Induction of ET-1, whose expression has been shown to be important in the 
pathogenesis of chronic heart disease (Krum, Denver et al. 2001), by C. pneumoniae has 
nőt been previously demonstrated.
Our findings demonstrate that infection of U937 cells with C. pneumoniae rapidly 
induces gene expression of transcription factors and cell-signaling molecules that then 
initiate a complex program of gene expression. Many of the large-scale changes in the 
expression we detected were in genes associated with various steps o f acute and chronic 
inflammation, including leukocyte chemotaxis, attachment, and activation. We alsó found 
the induction of a number of genes that could have considerable impact on the initiation and 
progression of atherosclerosis, including genes associated with lipid accumulation, 
vasoconstriction, tissue remodeling, and coaguíation.
5.3 We could fínd a pathobiotype specific Tyr-phosphorylation induction in the hőst 
epithelial cell. which was clearly different between the C. trachomatis mucosal (A-H) and 
non-mucosal strains (L1-L2-L3) as well as C. muridarum, C. caviae and C. pneumoniae. 
Using the chlamydial and hőst cell mRNA and protein synthesis inhibitors rifampicin and 
emetin, we alsó showed that this Tyr-phosphory lation uses the already synthesized 
proteins, and requires a verv short period of time, usually ~10 minutes to be induced. This 
rapid induction suggests, that this phosphorylation is linked to the chlamydial attachment 
and/or entry. There are at least two possible scenarios exist fór the induction of the tyrosine 
phosphorylation cascade. The fírst is that the Tyr-phosphorylated proteins have a hőst 
origin. In this case there is a chlamydia ligand that clearly distinguishes between the 
chlamydia pathobiotypes, and somehow the ligand-induced hőst protein tyrosine 
phosphorylation alsó follows this distinction. The chlamydial attachment is a well studied 
bút complex subject, and a number of chlamydial ligands has been implicated in this 
process including chlamydia hsp70 (Raulston, Davis et al. 2002), omcB (Stephens, 
Koshiyama et al. 2001) and probably the most widely accepted two: the abundant 
chlamydia surface molecule major outer membráné protein (MOMP) (Su, Zhang et al. 
1988; Su, Raymond et al. 1996), and the heparin and heparane sulphate-GAG on the 
chlamydial surface (Zhang and Stephens 1992). From the hőst side, the heparin and 
heparane sulphate-GAG attached plasma membráné protein was implicated mostly as a
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receptor (Byme 1978; Su, Raymond et al. 1996; Wuppermann, Hegemann et al. 2001). 
However, there are several indications that these MOMP-GAG or GAG-GAG interactions 
cannot be the source of the observed Tyr-phosphorylation. Firstly, the surface GAG 
composition of C. trachomatis L2 and E, and C. pneumoniae was found to be remarkably 
similar (Beswick, Travelstead et al. 2003). bút the Tyr-phosphorylation pattems were verv 
different between C. trachomatis Li and E versus C. pneumoniae in our experiments. 
Moreover, in the same study, heparin treatment of the target bronchial epithelial cells 
inhibited the infection of C. pneumoniae and C. trachomatis L2, bút nőt E, while the Tyr- 
phosphorylation was similar between L2 and E and there was no Tyr-phosphorylation 
induction in the case of C. pneumoniae in our study. In an other study, the heparin 
treatment of HeLa cells strongly (80%) inhibited the attachment o f C. trachomatis L2 to the 
hőst HeLa cells, bút had a various, bút generally much lower inhibitory effect on the 
attachment of C. trachomatis serovars B, C and G (2-35%) (Chen and Stephens 1997). The 
observed differences, that reílect the GAG-GAG interactions between different strains of 
chlamydia and the hőst cell does nőt correlate the Tyr-phosphorylation profilé we observed 
using these serovars. Stephens et al. provided further evidence that the chlamvdial GAG -  
hőst cell surface interaction is nőt the major source of the observed Tyr-phosphorylation 
(Stephens, Fawaz et al. 2000). They used heparin coated microbeads to mimic chlamvdial 
attachment and entry, bút the beads could onlv induce a single tyrosine phosphorylated 
bánd at the -80 kD region (C. muridarum induction zone), and there was no detectable 
tyrosine phosphorylation at the -70 kD region (C. trachomatis trachoma and LGV biovars 
induction zone).
The other frequently cited chlamvdial adhesin is the major outer membráné protein, 
which is a highlv expressed, variable surface molecule. The remarkable sequence variation 
suggests that the molecule has a target of the immuné response, and it has been shown 
before that has an important function as an adhesin (Su, Zhang et al. 1988; Su, Watkins et 
al. 1990; Su and Caldwell 1991). The MOMP-GAG interaction was showed previously 
(Su, Raymond et al. 1996): a recombinant MOMP (rMOMP) protein was capable to bind to 
a heparin and heparane-sulphate component of the hőst cell surface, and moreover, the 
rMOMP was able to competitively inhibit the binding of C. muridarum to the hőst HeLa 
cells. The fact that MOMP has a remarkable variation between the different strains, bút this
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sequence variation does nőt distinguish between C. trachomatis mucosal and non-mucosal 
biovars while the observed Tyr-phosphorylation does (Yuan, Zhang et al. 1989; Stothard, 
Boguslawski et al. 1998), suggests, that this ligand is nőt involved in Tyr-phosphorylation. 
We alsó could nőt detect an rMOMP induced Tyr-phosphorylation in HeLa cells even 
when we used various concentrations and timepoints (data nőt shown). Previous data 
indicates, that the chlamydial attachment and entry is a complex process involving more 
than one step. Carabeo et al. isolated a mutant CHO ceil line which was capable to bind C. 
trachomatis Li, bút the ehlamydia entry was inhibited intő these cells, suggesting that the 
entry is involving more than one step, and possibly more than one chlamydia-host cell 
iigand-receptor interaction (Carabeo and Hackstadt 2001). If we are applying this model to 
our results, the chlamvdia uses the surface MOMP and/or GAGs to attach the cells as a first 
“silent" step, and a second ligand to facilitate entry and trigger Tyr-phosphorylation. 
Among the chlamydial proteins, the polymorphic membráné protein (pmp) gene 
superfamily has the proper characteristics to be the putative chlamydial ligand, that induces 
the Tyr-phosphorylation. Somé polymorphic membráné proteins are expressed on the EB 
surface, are targets of neutralizing antibodies, and induce host-cell NF-kB signaling and 
cytokine secretion (Christiansen, Pedersen et al. 2000; Niessner, Kaun et al. 2003; Stothard, 
Tóth et al. 2003; Wehrl. Brinkmann et al. 2004). Moreover, Stothard et al. (Stothard, Tóth 
et al. 2003) showed substantial variation among pmp genes E, H. and I by restriction 
fragment length polymorphism analysis of C. trachomatis serovars. Of particular relevance 
to the present study was the íinding that such polymorphisms among pmp H correlated 
exactlv with the three major C. trachomatis disease groups, prompting Stothard et al. to 
suggest that the pmp may play a role in pathogenesis (Stothard, Tóth et al. 2003). Besides 
the Iigand-receptor interaction that triggers the tyrosine-phosphorylation, the tyrosine 
phoshphorylated proteins themselves are alsó unknown. Birkelund et al. labeled the hőst 
proteins with SJÍ prior to infection, and immunoprecipitated the tyrosine-phosphorylated 
proteins after infection. The autofluorography of the precipitated proteins revealed two 
major bands (97 and 68 kDa) that could be observed in the regular phosphotyrosine 
specifíc western blots as well. ít indicates that at least partially the tyrosine-phosphorylated 
proteins have a hőst cell origin. Based on the fact that the size o f the most strongly 
phosphorylated group of proteins is around 70 kD. Fawaz et al. proposed that this bánd
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could be the 85kD hőst cell protein cortactin (Fawaz, van Ooij et al. 1997), which has been 
described previously to be involved in actin cytoskeleton reorganization, a characteristic 
feature of chlamvdial entrv intő the hőst cells. They could colocalize the hőst cortactin to 
the chlamvdial inclusions, in a similar pattem than the observed Tyr-phosphorylation. 
However when they immunoprecipitated chlamydia infected cell lysates either with anti- 
cortactin they could nőt detect an increased phophorylation, indicating that the observed 
-70-85 kD protein is nőt the cortactin.
The second, more simple scenario of the chlamydia induced tyrosine 
phosphorylation Cascade is where there is a chlamydia ligand that differs between the 
chlamydia pathobiotypes and this protein becomes Tyr-phosphorylated during the 
attachment and/ or entrv. Our observation that strain-specific chlamydia-induced protein 
tyrosine phosphorylation pattems are common to humán and murine hőst cells supports this 
hypothesis. Induction of identical, strain-specific protein tyrosine phosphorylation profiles 
in cells írom distant hőst species argues against the interpretation that these proteins are 
conserved hőst proteins of mice and humans. Clifton et al. showed that a high molecular 
weight chlamydial protein (translocated actin-recruiting phosphoprotein - TARP) that could 
be involved in the local actin-cytoskeleton reorganization, is secreted intő the hőst cell 
cytoplasm via a Type III secretion mechanism, and phosphorylated (Clifton, Fields et al. 
2004). Type III mediated secretion of chlamydial effectors is a logical and highly favored 
hypothesis fór the delivery of chlamydial effectors to the hőst cytosol. Flowever, direct 
evidence fór a functional chlamydial type III secretion system is lacking and the most 
compelling indirect evidence that chlamydiae possess a functional type III apparátus comes 
from the secretion of putative chlamydial effectors by the Yersina heterologous expression 
assay (Fields, Mead et al. 2003). The other problem is that the observed size of the 
phosphorylated chlamydia protein was 150 kD, while in our studies the major 
phosphorylated bands were around 70kD, and we could nőt detect a 150 kD bánd at all. 
Accordingly. when we used an anti-TARP antibody, one prominent bánd was detected at 
the 150 kD region, bút no difference at the 70 kD region (data nőt shown). As a direct 
consequence of our results, the second scenario alsó should contain a Tyr-phosphorylation 
inducing chlamydial ligand that is different between the chlamydia pathobiotypes.
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We speculate that the 70-kDa pathobiotype tyrosine-phosphorylated protein(s) may 
be member(s) of the polymorphic outer membráné protein gene family. The pmp are a 
polymorphic superfamily of six or more genes, depending on the chlamydial strain, 
encoding large proteins (90 to 187 kJDa) with a distinct homology to tvpe V secreted 
autotransporters (Grimwood and Stephens 1999; Christiansen, Pedersen et al. 2000; 
Henderson and Lám 2001; Stothard. Tóth et al. 2003). Of interest, pmp genes are absent in 
the genome of the related parachlamydial svmbiont (UWE-25) of free-living amoebae 
(Horn, Collingro et al. 2004), implying a role fór the protein(s) in the infection of 
mammalian cells. Moreover, as we discussed above, the members of this family are clearly 
capable to distinguish between the chlamydial pathobiotypes. Intriguingly, the molecular 
mass of processed pmp is around 70 kDa, a size consistent with that observed fór the major 
tyrosine-phosphorylated protein complex observed during infection with human-adapted C. 
trachomatis strains in this study (Henderson and Lám 2001; Wehrl, Brinkmann et al. 
2004). Although the pmp(s) are the most important chlamydial proteins that fulfills the 
requirements fór both tyrosine-phosphorylation scenarios, the role of pmp genes in tyrosine 
phosphorylation is inconsistent with observations that C. pneumoniae and C. caviae 
possess full complements of pmp genes bút do nőt induce tyrosine phosphorylation. One 
possible explanation is that these pmp genes functionally differ; of the 21 C. pneumoniae 
pmp genes, onlv two can activate NF-kP (Niessner, Kaun et al. 2003). C. trachomatis and 
C. muridarum may retain a subset of pmpfs) that are stronger inducers of tyrosine 
phosphorylation. Altemately, C. pneumoniae and its genetically close relatíve, C. caviae, 
might alsó use unique factors, such as the Yersinia YopH protein phosphatase. to mask this 
signaling event (Bliska, Guan et al. 1991).
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The following results are considered növel
We detected First C.pneumoniae DNA, and C.pneumoniae-\lks structures in humán 
middle cerebral artery samples
We performed the first DNA-chip experiment to study the impact of C.pneumoniae 
on the gene expression of humán monocvtes discovering several previously nőt 
described bacterium induced hőst genes that can be linked to chlamydia-related 
chronic infections.
We described first that the Tyrosine phosphorvlation induction is a generál 
phenomenon of C.irachomatis infection.
- Our növel finding was, that the induced Tyrosine phosphorylation pattem is clearly 
different between C.trachomatis non-disseminating and disseminating strains.
We showed first that the various chlamydia strains induced Tyrosine 
phosphorylation pattem is very similar in humán and mouse epithelial cell lines, 
indicating that the observed Tyrosine phosphorylation have bacterial origin.
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